Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity Ravi MarwahDaniel XingSweet Ping Ng Review Open access 21 September 2023 Pages: 505 - 524
Seizure outcomes after resection of primary brain tumors in pediatric patients: a systematic review and meta-analysis Kalman A. KatlowitzPrazwal AthukuriHoward L. Weiner Review 14 September 2023 Pages: 525 - 533
Age and sex disparities in Latin-American adults with gliomas: a systematic review and meta-analysis Renée van′t HekJuan Luis Ortiz-HerreraTalia Wegman-Ostrosky Review 29 September 2023 Pages: 535 - 543
Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study Pim B. van der MeerLinda DirvenJohan A.F. Koekkoek Review Open access 27 September 2023 Pages: 545 - 555
Supramaximal resection based on en-bloc technique reduces tumor burden and prolongs survival in primary supratentorial lobar glioblastoma Tianshi QueGuanglong HuangSongtao Qi Research 02 October 2023 Pages: 557 - 568
Sexually dimorphic effect of H-ferritin genetic manipulation on survival and tumor microenvironment in a mouse model of glioblastoma Bhavyata Pandya SheshVonn WalterJames R. Connor Research 09 October 2023 Pages: 569 - 586
Long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in neurofibromatosis type 2 patients Putipun PuataweepongMantana DhanachaPornpan Yongvithisatid Research 13 September 2023 Pages: 587 - 595
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma Pejman Jabehdar MaralaniJames StewartArjun Sahgal Research 14 September 2023 Pages: 597 - 605
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses Thomas ZeyenDaniel PaechChristina Schaub Research Open access 20 September 2023 Pages: 607 - 616
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells Johanna VollmerJonas EckerTill Milde Research Open access 03 October 2023 Pages: 617 - 632
Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas Takuya FurutaTetsuya NegotoYasuo Sugita Research 14 September 2023 Pages: 633 - 641
Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study Chenggong ZengQunying YangZijun Zhen Research 28 September 2023 Pages: 643 - 653
Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018 David Y. A. DadeyZachary A. MedressStephen Skirboll Research 04 October 2023 Pages: 655 - 662
RAI-measured frailty predicts non-home discharge following metastatic brain tumor resection: national inpatient sample analysis of 20,185 patients Michael M. CovellAkshay WarrierChristian A. Bowers Research 03 October 2023 Pages: 663 - 670
Advancing personalized prognosis in atypical and anaplastic meningiomas through interpretable machine learning models Mert KarabacakPemla JagtianiKonstantinos Margetis Research 28 September 2023 Pages: 671 - 681
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes Cas S. DejonckheereJulian P. LayerGustavo R. Sarria Research Open access 09 October 2023 Pages: 683 - 691
Characterizing T-cell dysfunction and exclusion signatures in malignant peripheral nerve sheath tumors reveals susceptibilities to immunotherapy Archis R. BhandarkarShaan BhandarkarRobert J. Spinner Research 27 September 2023 Pages: 693 - 699
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors Alayna E. ErnsterAnjelica BodyAshley P. Ghiaseddin Research 07 October 2023 Pages: 701 - 710
Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma Sarah IglsederAnna IglsederChristoph Scherfler Case Study Open access 14 September 2023 Pages: 711 - 720
The impact of opioid administration for post gamma knife radiosurgery frame removal: a prospective quality-improvement study Jason HsiehWei WeiLilyana Angelov Case Study 25 September 2023 Pages: 721 - 728
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses Ai Seon KuanChi-Lu ChiangCheng-Chia Lee Case Study 18 September 2023 Pages: 729 - 739
The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis Chelsea KotchStephanie J. SiMichael J. Fisher Case Study 07 October 2023 Pages: 741 - 747
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial Johannes WellerThomas ZeyenUlrich Herrlinger Case Study Open access 03 October 2023 Pages: 749 - 755
Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis G. R. BorstR. Post Correspondence 09 October 2023 Pages: 757 - 758
Correction to: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44 Ling LiMei-Ying ShaoZhu-Chu Chen Correction 22 September 2023 Pages: 759 - 759
